Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Clinical trial NCT07046494 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07046494
- Sponsor
- Rapport Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-25
- Primary completion
- 2026-08-05
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.